Sinopharm Group Co., Ltd. logo

Sinopharm Group Co., Ltd. (1099)

Market Closed
11 Aug, 08:00
HKEX HKEX
16. 83
HKD
-0.23
-1.3482%
HKD
62.57B Market Cap
6.6 P/E Ratio
6.89% Div Yield
3.37M Volume
0 Eps
17.06 HKD
Previous Close
Add Transaction
Day Range
16.64 17.25
Year Range
15.28 22.34
Want to track 1099 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1099 closed today lower at 16.83 HKD, a decrease of -1.3482% from yesterday's close, completing a monthly increase of 4.8598% or 0.78 HKD. Over the past 12 months, 1099 stock lost -13.4259%.
The next announced payment will be in In 1 week on Aug 18, 2026 for a total of 0.79 HKD.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

1099 Chart

People also search for

WH Group Limited
8.16 HKD
+1.3035%
China Resources Mixc Lifestyle Services Ltd.
39.82 HKD
-0.8466%
Budweiser Brewing Company APAC Limited
6.41 HKD
-0.9281%
Eastroc Beverage (Group) Co., Ltd.
118.5 HKD
-5.427%
China Resources Beer
22.16 HKD
-1.6859%

Sinopharm Group Co., Ltd. (1099) FAQ

What is the stock price today?

The current price is 16.83 HKD.

On which exchange is it traded?

Sinopharm Group Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 1099.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.89%.

What is its market cap?

As of today, the market cap is 62.57B.

Has Sinopharm Group Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Sinopharm Group Co., Ltd. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Wanyong Lian CEO
HKEX Exchange
Y8008N107 CUSIP
CN Country
94,910 Employees
23 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Sinopharm Group Co. Ltd., with its pivotal role outlined within the healthcare sector of the People's Republic of China, operates through its widespread network focusing on the wholesale and retail aspects of pharmaceuticals, medical devices, and various healthcare products. Founded in 2003 and positioned strategically in Shanghai, Sinopharm, through its diversified business model, caters to a comprehensive range of healthcare needs across the nation. It is divided operationally into four primary segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business, ensuring a broad coverage across different healthcare requirements. Beyond the national boundaries, Sinopharm has also established its mark by offering international pharmaceutical and healthcare product manufacturers a host of value-added services including distribution, logistics, and market access services. Notably, Sinopharm Group Co. Ltd. functions under the corporate umbrella of Sinopharm Industrial Investment Co., Ltd., strengthening its corporate synergy and reinforcing its commitment to advancing healthcare access and innovation.

Products and Services

The extensive portfolio of products and services offered by Sinopharm Group Co. Ltd. encapsulates the essence of a comprehensive healthcare provider, attending to a wide spectrum of consumer and business needs within the healthcare industry.

    Pharmaceutical Distribution: Serving as a cornerstone of Sinopharm's offerings, this segment ensures a seamless supply of pharmaceutical products to key stakeholders in the healthcare chain including hospitals, retail pharmacies, clinics, and other distribution channels. Accompanying the distribution are logistics and value-added services catering to both domestic and international markets, aimed at enhancing the efficiency and reach of healthcare solutions.

    Medical Devices: Acknowledging the critical role of technology in modern healthcare, Sinopharm distributes a vast array of medical devices. This initiative bridges the gap between innovative medical technologies and healthcare institutions, thereby facilitating cutting-edge treatments and diagnostics.

    Retail Pharmacy: Through its extensive networks of retail drug stores, which are both owned and franchised, Sinopharm makes healthcare products easily accessible to the general public. This network is a vital component in ensuring community health and wellness by offering a diverse range of pharmaceuticals and related products.

    Other Business Segment: This diverse category includes the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies, further underpining the comprehensiveness of Sinopharm's offerings. Additionally, the group is involved in property management, distribution of Chinese herbal medicines, antibiotics, biological products, and a suite of professional services ranging from IT development, medicine consultation to market research, and project investment management. This amalgamation of services accentuates Sinopharm's integrated approach towards healthcare.

Contact Information

Address: Sinopharm Group Building
Phone: 86 21 2305 2666